Literature DB >> 12646242

The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats.

Zhang Chunyu1, Du Junbao, Bu Dingfang, Yan Hui, Tang Xiuying, Tang Chaoshu.   

Abstract

Hypoxic pulmonary hypertension (HPH) is an important pathophysiological process. The mechanism of HPH is still not fully understood. Recent studies showed that hydrogen sulfide (H(2)S) could relax vascular smooth muscles and inhibit the proliferation of cultured vascular smooth muscle cells. Our study showed that both the gene expression of cystathionine gamma-lyase (CSE), one of the H(2)S generating enzymes, and the activity of CSE were suppressed in lung tissues during HPH. And the plasma level of H(2)S was decreased during HPH. Exogenous supply of H(2)S could increase the plasma level of H(2)S, enhance CSE activity, and up-regulate CSE gene expression in lung tissue. At the same time, exogenous supply of H(2)S could oppose the elevation of pulmonary arterial pressure and lessen the pulmonary vascular structure remodeling during HPH. The results showed that endogenous H(2)S system was involved and exogenous H(2)S could exert beneficial effect on the pathogenesis of HPH.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646242     DOI: 10.1016/s0006-291x(03)00256-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  54 in total

Review 1.  Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter.

Authors:  John L Wallace; Rui Wang
Journal:  Nat Rev Drug Discov       Date:  2015-04-07       Impact factor: 84.694

2.  Development of hydrogen sulfide-based therapeutics for cardiovascular disease.

Authors:  Benjamin L Predmore; David J Lefer
Journal:  J Cardiovasc Transl Res       Date:  2010-07-14       Impact factor: 4.132

3.  Role of hydrogen sulfide in severe burn injury-induced inflammation in mice.

Authors:  Jing Zhang; Selena Wei Shan Sio; Shabbir Moochhala; Madhav Bhatia
Journal:  Mol Med       Date:  2010-04-28       Impact factor: 6.354

4.  H2S mitigates severe acute pancreatitis through the PI3K/AKT-NF-κB pathway in vivo.

Authors:  Chun-Yan Rao; Lan-Ying Fu; Chang-Lun Hu; Dai-Xing Chen; Tian Gan; Yi-Cheng Wang; Xiao-Yan Zhao
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

5.  Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat.

Authors:  Madhav Bhatia; Jenab Sidhapuriwala; Shabbir M Moochhala; Philip K Moore
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia.

Authors:  Marika Collin; Farhana B M Anuar; Oliver Murch; Madhav Bhatia; Philip K Moore; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 7.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

8.  The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.

Authors:  Zhen Liu; Yi Han; Ling Li; Hui Lu; Guoliang Meng; Xiaozhen Li; Mohammed Shirhan; Meng Teng Peh; Liping Xie; Suming Zhou; Xiaowei Wang; Qi Chen; Weilu Dai; Choon-Hong Tan; Shiyang Pan; Philip K Moore; Yong Ji
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Role of hydrogen sulfide in portal hypertension and esophagogastric junction vascular disease.

Authors:  Chao Wang; Juan Han; Liang Xiao; Chang-E Jin; Dong-Jian Li; Zhen Yang
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 10.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.